Back to Search
Start Over
Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case Series
- Source :
- Case Reports in Oncological Medicine, Vol 2015 (2015)
- Publication Year :
- 2015
- Publisher :
- Wiley, 2015.
-
Abstract
- Metformin is derived from galegine, a natural ingredient, and recent studies have suggested that metformin could enhance the antitumor effects of hormone ablative therapy or chemotherapy and reduce prostate cancer-specific mortality. Zyflamend is a combination of herbal extracts that reduces inflammation and comprises turmeric, holy basil, green tea, oregano, ginger, rosemary, Chinese goldthread, hu zhang, barberry, and basil skullcap. We propose a maintenance regimen with metformin and/or Zyflamend that targets cancer stem cells and the tumor microenvironment to keep the cancer dormant and prevent it from activation from dormancy. Herein, we report the clinical course of four patients who experienced a clinical response after treatment with metformin and/or Zyflamend.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 20906706 and 20906714
- Volume :
- 2015
- Database :
- Directory of Open Access Journals
- Journal :
- Case Reports in Oncological Medicine
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.47618289655844a383d719626eb485b6
- Document Type :
- article
- Full Text :
- https://doi.org/10.1155/2015/471861